New York, NY (March 14, 2017) – The U.S. Food and Drug Administration (FDA) announced it has approved the use of pembrolizumab (KEYTRUDA ®) to treat patients with refractory classical Hodgkin lymphoma (cHL), or those who have relapsed after three…
By: Ann LaCasce, MD and Sonali M. Smith, MD The last decade has seen a number of exciting developments in lymphoma research, with new therapies, improved treatment strategies, and a more developed understanding of lymphoma biology improving patient treatment and…
Hans-Guido Wendel, MD (Memorial Sloan Kettering Cancer Center) is a two-time recipient of the Lymphoma Research Foundation’s Follicular Pathways Grant, and a member of LRF’s Scientific Advisory Board. As befits the grant name, Dr. Wendel’s research focuses on the microbiology…
New York, NY (January 6, 2017) – The Lymphoma Research Foundation’s (LRF) CEO, Meghan Gutierrez, was honored to represent the lymphoma community at the White House, during the Cancer Moonshot Open Innovation meeting, to discuss reaching Cancer Moonshot goals. Cancer Moonshot began…
ASH Meeting to Feature Lymphoma Research Foundation Scientific Advisory Board Members and Research Grantees in 2016 New York, NY (December 1, 2016) – The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma…
More Than 200 VIPs from New York City Attend Joint Fundraiser with The Paul Foundation and the Lymphoma Research Foundation to Benefit Blood Cancer Research New York, NY (December 1, 2016) –The Lymphoma Research Foundation (LRF) – the nation’s largest…
Science Translational Medicine report led by Lymphoma Research Foundation Scientific Advisory Board members and LRF Grantees As personalized medicine becomes increasingly popular, researchers continue to discover ways to ensure that the right patient receives the right treatment at the right…
The Most Comprehensive Lymphoma Education Program for Patients and their Loved Ones Held in Chicago, IL for First Time Chicago, IL (November 7, 2016) – The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative…
Hundreds Celebrate Together to Raise Funds for Lymphoma Research at Mandarin Oriental New York New York, NY (October 18, 2017) – The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and…
Hundreds of Riders from Across the Nation Participate in Premier Blood Cancer Awareness Cycling Event New York, NY (October 7, 2016) –The Lymphoma Research Foundation (LRF) – the nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and…